Cargando…

Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis

Whether 2(nd)-line-chemotherapy (2LCTX) + best-supportive-care (BSC) benefits patients with advanced biliary tract cancer (aBTC) more than BSC alone is unclear. We therefore conducted a propensity-score-based comparative effectiveness analysis of overall survival (OS) outcomes in 80 patients with me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moik, Florian, Riedl, Jakob M., Winder, Thomas, Terbuch, Angelika, Rossmann, Christopher H., Szkandera, Joanna, Bauernhofer, Thomas, Kasparek, Anne-Katrin, Schaberl-Moser, Renate, Reicher, Andreas, Prinz, Felix, Pichler, Martin, Stöger, Herbert, Stotz, Michael, Gerger, Armin, Posch, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447553/ https://www.ncbi.nlm.nih.gov/pubmed/30944390 http://dx.doi.org/10.1038/s41598-019-42069-1

Ejemplares similares

Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study
por: Riedl, Jakob Michael, et al.
Publicado: (2017)

Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting
por: Riedl, Jakob Michael, et al.
Publicado: (2017)

Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy
por: Klöckl, Marie-Christin, et al.
Publicado: (2020)

Risk stratification for febrile neutropenia in patients with testicular germ cell tumors
por: Terbuch, Angelika, et al.
Publicado: (2018)

MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients
por: Terbuch, Angelika, et al.
Publicado: (2018)

Long-term cardiovascular complications in stage I seminoma patients
por: Terbuch, A., et al.
Publicado: (2017)

Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy
por: Mollnar, S., et al.
Publicado: (2020)

Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis
por: Müller, Moritz, et al.
Publicado: (2021)

Risk stratification for venous thromboembolism in patients with testicular germ cell tumors
por: Bezan, Angelika, et al.
Publicado: (2017)

The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
por: Stotz, M, et al.
Publicado: (2014)

Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patients
por: Stelzl, Adrian, et al.
Publicado: (2020)

Evaluation of Uric Acid as a Prognostic Blood-Based Marker in a Large Cohort of Pancreatic Cancer Patients
por: Stotz, Michael, et al.
Publicado: (2014)

A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
por: Absenger, G, et al.
Publicado: (2013)

Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
por: Posch, Florian, et al.
Publicado: (2017)

Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection
por: Stotz, Michael, et al.
Publicado: (2016)

Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study
por: Posch, Florian, et al.
Publicado: (2017)

External Validation of the Derived Neutrophil to Lymphocyte Ratio as a Prognostic Marker on a Large Cohort of Pancreatic Cancer Patients
por: Szkandera, Joanna, et al.
Publicado: (2013)

Reply: Comment on ‘A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients'
por: Szkandera, J, et al.
Publicado: (2013)

C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study
por: Riedl, Jakob M., et al.
Publicado: (2020)

Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients
por: Klocker, Eva Valentina, et al.
Publicado: (2020)

MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms
por: Posch, Florian, et al.
Publicado: (2021)

Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer: A retrospective analysis
por: Asamer, Eva, et al.
Publicado: (2018)

LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy
por: Szkandera, J, et al.
Publicado: (2015)

Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
por: Szkandera, J, et al.
Publicado: (2014)

Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial
por: Riedl, Jakob M., et al.
Publicado: (2021)

MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients
por: Lembeck, Anna L., et al.
Publicado: (2020)

External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients
por: Barth, Dominik Andreas, et al.
Publicado: (2020)

Molecular profiling of soft-tissue sarcomas with FoundationOne(®) Heme identifies potential targets for sarcoma therapy: a single-centre experience
por: Scheipl, Susanne, et al.
Publicado: (2021)

The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic Cancer
por: Stotz, Michael, et al.
Publicado: (2020)

Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study
por: Barth, Dominik A., et al.
Publicado: (2022)

Pre-Treatment Anemia Is a Poor Prognostic Factor in Soft Tissue Sarcoma Patients
por: Szkandera, Joanna, et al.
Publicado: (2014)

Evaluation of autoantibodies as predictors of treatment response and immune‐related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan‐cancer study
por: Barth, Dominik A., et al.
Publicado: (2022)

Reply: Comment on ‘Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients'
por: Szkandera, J, et al.
Publicado: (2013)

Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
por: Szkandera, J, et al.
Publicado: (2013)

Hedgehog Signaling Pathway in Ovarian Cancer
por: Szkandera, Joanna, et al.
Publicado: (2013)

MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive Review
por: Smolle, Maria Anna, et al.
Publicado: (2017)

Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients
por: Szkandera, J, et al.
Publicado: (2013)

Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials
por: Moik, Florian, et al.
Publicado: (2020)

Systemic Inflammation and Activation of Haemostasis Predict Poor Prognosis and Response to Chemotherapy in Patients with Advanced Lung Cancer
por: Moik, Florian, et al.
Publicado: (2020)

MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon response
por: Prinz, Felix, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_65n2h07uhkdi2hsbgdcc2issfo